Laboratory Corporation of America is a diagnostics & research business based in the US. Laboratory Corporation of America shares (LH.US) are listed on the NYSE and all prices are listed in US dollars. Its last market close was $222.00 – an increase of 1.38% over the previous day. Laboratory Corporation of America employs 60,000 staff and has a trailing 12-month revenue of around $15.1 billion.
Only you can make the decision on the time to leap... but here's some supporting information and analysis.
Over the last 12 months, Laboratory Corporation of America's shares have ranged in value from as little as $178.3718 up to $220.8248. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Laboratory Corporation of America's is 1.052. This would suggest that Laboratory Corporation of America's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Historical closes compared with the last close of $222
| 1 week (2023-11-28) | 4.55% |
|---|---|
| 1 month (2023-11-05) | 5.97% |
| 3 months (2023-09-05) | 8.88% |
| 6 months (2023-06-05) | 17.86% |
| 1 year (2022-12-05) | 10.86% |
| 2 years (2021-12-05) | -8.82% |
| 3 years (2020-12-05) | 33.12% |
| 5 years (2018-12-05) | 84.35% |
The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Laboratory Corporation of America P/E ratio, PEG ratio and EBITDA
Laboratory Corporation of America's current stock price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 23x. In other words, Laboratory Corporation of America stocks trade at around 23x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the United States stock markets on average as of November 10, 2023 (20.44). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Laboratory Corporation of America's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.1223. Higher PEG ratios such as this can be interpreted as meaning the shares offer worse value given the current rate of growth.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Laboratory Corporation of America's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.
Laboratory Corporation of America's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $2.1 billion.
The EBITDA is a measure of a Laboratory Corporation of America's overall financial performance and is widely used to measure a its profitability.